Key Metrics of Trulieve Cannabis Corp.
Revenue$1.1B▼ 7.3% YoYFY 2023
Operating income−$222M▼ 541.8% YoY
Net profit−$527M▼ 114.1% YoY
Shareholders' equity$1.4B
Market cap$2.2BTRLV · $11.60
Competitors10identified
About Trulieve Cannabis Corp.
Sectors
Company details
- Listed
- NYSE: TRLV
Operational Areas of Trulieve Cannabis Corp.
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameTrulieve Cannabis Corp.
TickerTRLV
ExchangeNYSE
CountryUnited States
SEC CIK0001754195
Listed since—
Industry Medicinal Chemicals and Botanical Products
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Website—
US market & SEC filings
TRLV · NYSE · SEC CIK 0001754195
Last price · 05 Nov 2026
$11.60
+0.52%
Market cap$2.2B
P/E—On FY 2023 diluted EPS
Volume2,248,881
SectorHealth Care Medicinal Chemicals and Botanical Products
Country · IPOUnited States
TRLV share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Trulieve Cannabis Corp.
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.